Summary & Overview
HCPCS P9038: Irradiated Red Blood Cells, Each Unit
HCPCS Level II code P9038 denotes a single unit of irradiated red blood cells used in transfusion therapy to mitigate the risk of transfusion-associated graft-versus-host disease. This supply-level code is relevant across inpatient and outpatient hospital settings, including blood banks and infusion centers, and is a critical component of blood management for immunocompromised patients. National attention to P9038 reflects its clinical importance and cost implications within hospital transfusion services. Key payers in this national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, where it is typically billed, and what payers commonly cover. The publication provides benchmarking expectations, coverage considerations, and policy updates affecting billing and reimbursement for blood product services. It also outlines the operational implications for supply chain, hospital transfusion services, and billing workflows. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code P9038 represents irradiated red blood cells, each unit. This service involves the provision of a single unit of red blood cells that has undergone irradiation to reduce the risk of transfusion-associated graft-versus-host disease. Service type: transfusion blood product. Typical site of service: hospital inpatient or outpatient transfusion center, including hospital blood bank and specialty infusion units.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric inpatient or outpatient undergoing transfusion for anemia, hemorrhage, or hematologic therapy and requires irradiated red blood cells to prevent transfusion-associated graft-versus-host disease. Common scenarios include an oncology patient receiving high‑dose chemotherapy or hematopoietic stem cell transplant, an immunocompromised patient (e.g., receiving alemtuzumab or fludarabine), or a neonatal/pediatric patient where irradiation is required by institutional protocol. The clinical workflow: the treating physician documents the indication and orders P9038 in the blood bank information system; the transfusion service verifies patient identifiers and indication, selects compatible units, performs irradiation per protocol, issues and labels each irradiated unit, and the nursing team performs bedside verification and administers the transfusion while monitoring for reactions. Documentation in the medical record includes indication, consent if required, unit identifiers, irradiation dose/time, pre‑ and post‑transfusion vitals, and any adverse events.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no other modifier applies to the service |